Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 27 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-27-2023-6

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 27, 2023, titled "Zydus receives final approval from the USFDA for Plerixafor Injection USP, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases